Tag: biosimilar

March 21, 2024
New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.

READ MORE
May 16, 2022
IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.

READ MORE
January 17, 2022
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

READ MORE
January 9, 2020
Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

READ MORE
December 9, 2019
New Drug Developments Impacting Comp

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

READ MORE
lockenvelopephone-handsetmagnifiermenucross-circle